Look for formulations that specifically mention complexion enhancer properties
The newly identified 3G10 epitope involves amino acid residues from both N-Ag I and II sites, including VP1 GH-loop residues (Ser221, Asp226, Leu228), VP2 EF-loop residue (Thr168) from N-Ag II site, and VP1 BC-loop residues (Asn100, Lys101, Asp102) and EF-loop residue (Glu168) from N-Ag I site (Supplementary Tables 2 and 3), therefore suggesting that 3G10 targets a novel N-Ag site which is more complex than the classical N-Ag sites I to III
The QE-MS was equipped with a HESI source used in the positive ion mode with the following instrument parameters: sheath gas, 40
These legal developments illustrate a critical opportunity for victims to seek justice and compensation
doi: 10.1046/j.1563-2571.2000.00106.x 13 Pecori GiraldiFMoroM
Bridgewater, NJ: Sanofi-aventis U.S.;2019